ArticleMolecules (Basel, Switzerland)2022

The Reversible Carnitine Palmitoyltransferase 1 Inhibitor (Teglicar) Ameliorates the Neurodegenerative Phenotype in a Drosophila Huntington's Disease Model by Acting on the Expression of Carnitine-Related Genes.

Carla Bertapelle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.